Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion type Assertion NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_head.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion description "[They are attractive candidates for liver cancer therapy given that GPC3 and mesothelin show high expression in HCC and CCA, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_provenance.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion evidence source_evidence_literature NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_provenance.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion SIO_000772 21942912 NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_provenance.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion wasDerivedFrom befree-20150227 NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_provenance.
- NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_assertion wasGeneratedBy ECO_0000203 NP426966.RAxRveIAV52Qn0f7pY7hSpEUD3as2UdxjsKEOp-uN9fsU130_provenance.